Company profile

Ipsen specializes in the research, development, manufacturing and marketing of medications. Sales break down by family of products as follows:
  • specialty drugs (86.5%). Sales break down by therapeutic area between oncology (78.1%), neuroscience (18.3%) and rare diseases (3.6%);
  • consumer healthcare products (13.5%): products used in the treatment of gastrointestinal disorders, neurodegenerative pathologies and rheumatological disorders.
At the end of 2018, the group had 3 research centers located in France, the United Kingdom and the United States, and 5 production sites worldwide. Sales are distributed geographically as follows: France (12.7%), Germany (8.3%), Italy (4.6%), the United Kingdom (4.3%), Spain (4.1%), Europe (19.9%), North America (27.7%), Asia (9.3%) and other (9.1%).

Source: Cofisem - Last Update: 30 Aug 2019
Key Executives
Chief Executive Officer David Meek
Chief Financial Officer Aymeric Le Chatelier
VP, Communication Christian Marcoux
General Counsel Francois Garnier
Director Research & Development Alexandre Lebeaut
Human Resources Director Regis Mulot
Source: Cofisem - Last Update: 30 Aug 2019
Key figures
Millenium 2018 2017 2016 2015 2014
Net sales 2,224,800 1,908,700 1,584,600 1,443,900 1,274,800
Income from ordinary activities 2,348,400 2,011,700 1,671,100 1,520,200 1,332,400
Operating income 519,400 397,200 304,600 244,000 221,400
Cost (net) of financial indebtedness -5,300 -8,100 -4,900 -2,900 -3,000
Equity-accounted companies' contribution to results 1,100 1,400 1,900 2,500 1,900
Net profit from discontinued activities 2,100 2,200 100 600 -500
Net income 389,100 272,900 226,500 190,800 154,000
Net income (Group share) 389,500 272,300 225,900 189,900 153,500
Fiscal year end 12.18 12.17 12.16 12.15 12.14
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards
Source: Cofisem - Last Update: 30 Aug 2019
Shareholder information
Mayroy 56.40 %
Free float 41.32 %
Group-owned stock 0.89 %
Source: Cofisem - Last Update: 05 Apr 2019

Address

Ipsen

65 Quai Georges Gorse
FR-92100 Boulogne-Billancourt
France
Source: Cofisem - Last Update: 30 Aug 2019

Contact

David Schilansky
Phone number: +33 1 44 30 43 88
Source: Cofisem - Last Update: 30 Aug 2019